Stay updated on Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 has been added, and the previous funding/operating status notice (Revision: v3.4.1) has been removed.SummaryDifference0.5%

- Check20 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH operating status was added. The site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedUI text updates were applied, adding 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision tag 'v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays Revision: v3.3.4 in place of Revision: v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedThe Locations section now lists Michigan and Ohio as study sites and the page revision updated to v3.3.3. The HHS Vulnerability Disclosure link and the previous Michigan/Ohio Locations entries were removed.SummaryDifference0.4%

- Check92 days agoChange DetectedPublication notes now state that PubMed auto-fill may not all be about the study. The revision version has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.